Drug project high-priority medications: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
mNo edit summary
Line 8: Line 8:
<div style="float: left; padding: .5ex 0; font-weight: bold; background-color: #CEDFF2; border: 2px solid #999; border-bottom: 0; border-left: 0; font-size: 90%">&nbsp;&nbsp;&nbsp;[[Drug project high-priority medications|High-Priority Medications]]&nbsp;&nbsp;&nbsp;</div>
<div style="float: left; padding: .5ex 0; font-weight: bold; background-color: #CEDFF2; border: 2px solid #999; border-bottom: 0; border-left: 0; font-size: 90%">&nbsp;&nbsp;&nbsp;[[Drug project high-priority medications|High-Priority Medications]]&nbsp;&nbsp;&nbsp;</div>
</div>
</div>
<div style="clear:both; width: 95%; border: 3px solid #999; padding: 1em 1em; font-size: 120%;">
<div style="clear:both; width: 95%; border: 3px solid #999; padding: 1em 1em;">
==WikiDoc Drug Project — High-Priority Medications==
==WikiDoc Drug Project — High-Priority Medications==


Line 16: Line 16:


====List of high-priority medications====
====List of high-priority medications====
{| class="wikitable"
| align="center" style="background:#f0f0f0;"|'''Year'''
| align="center" style="background:#f0f0f0;"|'''No.'''
| align="center" style="background:#f0f0f0;"|'''Brand Name'''
| align="center" style="background:#f0f0f0;"|'''Active Ingredient'''
| align="center" style="background:#f0f0f0;"|'''Page Link'''
| align="center" style="background:#f0f0f0;"|'''DailyMed Search'''
| align="center" style="background:#f0f0f0;"|'''Approval Date'''
|-
| 2019||12||Polivy||Polatuzumab vedotin-piiq||[[Polatuzumab vedotin-piiq]]||Polatuzumab vedotin-piiq||6/10/2019
|-
| 2019||11||Piqray||Alpelisib||[[Alpelisib]]||Alpelisib||5/24/2019
|-
| 2019||10||Vyndaqel||Tafamidis meglumine||[[Tafamidis meglumine]]||Tafamidis meglumine||5/3/2019
|-
| 2019||9||Skyrizi||Risankizumab-rzaa||[[Risankizumab-rzaa]]||Risankizumab-rzaa||4/23/2019
|-
| 2019||8||Balversa||Erdafitinib||[[Erdafitinib]]||Erdafitinib||4/12/2019
|-
| 2019||7||Evenity||Romosozumab-aqqg||[[Romosozumab-aqqg]]||Romosozumab-aqqg||4/9/2019
|-
| 2019||6||Mayzent||Siponimod||[[Siponimod]]||Siponimod||3/26/2019
|-
| 2019||5||Sunosi||Solriamfetol||[[Solriamfetol]]||Solriamfetol||3/20/2019
|-
| 2019||4||Zulresso||Brexanolone||[[Brexanolone]]||Brexanolone||3/19/2019
|-
| 2019||3||Egaten||Triclabendazole||[[Triclabendazole]]||Triclabendazole||2/13/2019
|-
| 2019||2||Cablivi||Caplacizumab-yhdp||[[Caplacizumab-yhdp]]||Caplacizumab-yhdp||2/6/2019
|-
| 2019||1||Jeuveau||Prabotulinumtoxina-xvfs||[[Prabotulinumtoxina-xvfs]]||Prabotulinumtoxina-xvfs||2/1/2019
|-
| 2018||59||Ultomiris||Ravulizumab||[[Ravulizumab]]||Ravulizumab||12/21/2018
|-
| 2018||58||Elzonris||Tagraxofusp-erzs||[[Tagraxofusp-erzs]]||Tagraxofusp-erzs||12/21/2018
|-
| 2018||57||Asparlas||Calaspargase pegol-mknl||[[Calaspargase pegol-mknl]]||Calaspargase pegol-mknl||12/20/2018
|-
| 2018||56||Motegrity||Prucalopride||[[Prucalopride]]||Prucalopride||12/14/2018
|-
| 2018||55||Xospata||Gilteritinib||[[Gilteritinib]]||Gilteritinib||11/28/2018
|-
| 2018||54||Firdapse||Amifampridine||[[Amifampridine]]||Amifampridine||11/28/2028
|-
| 2018||53||Vitrakvi||Larotrectinib||[[Larotrectinib]]||Larotrectinib||11/26/2018
|-
| 2018||52||Daurismo||Glasdegib||[[Glasdegib]]||Glasdegib||11/21/2018
|-
| 2018||51||Gamifant||Emapalumab-lzsgemapalumab-lzsg||[[Emapalumab-lzsgemapalumab-lzsg]]||Emapalumab-lzsgemapalumab-lzsg||11/20/2018
|-
| 2018||50||Aemcolo||Rifamycin||[[Rifamycin]]||Rifamycin||11/16/2018
|-
| 2018||49||Yupelri||Revefenacin||[[Revefenacin]]||Revefenacin||11/9/2018
|-
| 2018||48||Lorbrena||Lorlatinib||[[Lorlatinib]]||Lorlatinib||11/2/2018
|-
| 2018||47||Xofluza||Baloxavir marboxil||[[Baloxavir marboxil]]||Baloxavir marboxil||10/24/2018
|-
| 2018||46||Talzenna||Talazoparib||[[Talazoparib]]||Talazoparib||10/16/2018
|-
| 2018||45||Tegsedi||Inotersen||[[Inotersen]]||Inotersen||10/5/2018
|-
| 2018||44||Revcovi||Elapegademase-lvlr||[[Elapegademase-lvlr]]||Elapegademase-lvlr||10/5/2018
|-
| 2018||43||Nuzyra||Omadacycline||[[Omadacycline]]||Omadacycline||10/2/2018
|-
| 2018||42||Seysara||Sarecycline||[[Sarecycline]]||Sarecycline||10/1/2018
|-
| 2018||41||Libtayo||Cemiplimab-rwlc||[[Cemiplimab-rwlc]]||Cemiplimab-rwlc||9/28/2018
|-
| 2018||40||Vizimpro||Dacomitinib||[[Dacomitinib]]||Dacomitinib||9/27/2018
|-
| 2018||39||Emgality||Galcanezumab-gnlm||[[Galcanezumab-gnlm]]||Galcanezumab-gnlm||9/27/2018
|-
| 2018||38||Copiktra||Duvelisib||[[Duvelisib]]||Duvelisib||9/24/2018
|-
| 2018||37||Ajovy||Fremanezumab-vfrm||[[Fremanezumab-vfrm]]||Fremanezumab-vfrm||9/14/2018
|-
| 2018||36||Lumoxiti||Moxetumomab pasudotox-tdfk||[[Moxetumomab pasudotox-tdfk]]||Moxetumomab pasudotox-tdfk||9/13/2018
|-
| 2018||35||Pifeltro||Doravirine||[[Doravirine]]||Doravirine||8/30/2018
|-
| 2018||34||Xerava||Eravacycline||[[Eravacycline]]||Eravacycline||8/27/2018
|-
| 2018||33||Takhzyro||Lanadelumab||[[Lanadelumab]]||Lanadelumab||8/23/2018
|-
| 2018||32||Oxervate||Cenegermin-bkbj||[[Cenegermin-bkbj]]||Cenegermin-bkbj||8/22/2018
|-
| 2018||31||Diacomit||Stiripentol||[[Stiripentol]]||Stiripentol||8/20/2018
|-
| 2018||30||Galafold||Migalastat||[[Migalastat]]||Migalastat||8/10/2018
|-
| 2018||29||Annovera||Segesterone acetate and ethinyl estradiol vaginal system||[[Segesterone acetate and ethinyl estradiol vaginal system]]||Segesterone acetate and ethinyl estradiol vaginal system||8/10/2018
|-
| 2018||28||Onpattro||Patisiran||[[Patisiran]]||Patisiran||8/10/2018
|-
| 2018||27||Poteligeo||Mogamulizumab-kpkc||[[Mogamulizumab-kpkc]]||Mogamulizumab-kpkc||8/8/2018
|-
| 2018||26||Mulpleta||Lusutrombopag||[[Lusutrombopag]]||Lusutrombopag||7/31/2018
|-
| 2018||25||Omegaven||Fish oil triglycerides||[[Fish oil triglycerides]]||Fish oil triglycerides||7/27/2018
|-
| 2018||24||Orilissa||Elagolix sodium||[[Elagolix sodium]]||Elagolix sodium||7/23/2018
|-
| 2018||23||Krintafel||Tafenoquine||[[Tafenoquine]]||Tafenoquine||7/20/2018
|-
| 2018||22||Tibsovo||Ivosidenib||[[Ivosidenib]]||Ivosidenib||7/20/2018
|-
| 2018||21||TPOXX||Tecovirimat||[[Tecovirimat]]||Tecovirimat||7/13/2018
|-
| 2018||20||Braftovi||Encorafenib||[[Encorafenib]]||Encorafenib||6/27/2018
|-
| 2018||19||Mektovi||Binimetinib||[[Binimetinib]]||Binimetinib||6/27/2018
|-
| 2018||18||Zemdri||Plazomicin||[[Plazomicin]]||Plazomicin||6/25/2018
|-
| 2018||17||Epidioloex||Cannabidiol||[[Cannabidiol]]||Cannabidiol||6/25/2018
|-
| 2018||16||Moxidectin||Moxidectin||[[Moxidectin]]||Moxidectin||6/13/2018
|-
| 2018||15||Olumiant||Baricitinib||[[Baricitinib]]||Baricitinib||5/31/2018
|-
| 2018||14||Palynziq||Pegvaliase-pqpz||[[Pegvaliase-pqpz]]||Pegvaliase-pqpz||5/24/2018
|-
| 2018||13||Doptelet||Avatrombopag||[[Avatrombopag]]||Avatrombopag||5/21/2018
|-
| 2018||12||Lokelma||Sodium zirconium cyclosilicate||[[Sodium zirconium cyclosilicate]]||Sodium zirconium cyclosilicate||5/18/2018
|-
| 2018||11||Aimovig||Erenumab-aooe||[[Erenumab-aooe]]||Erenumab-aooe||5/17/2018
|-
| 2018||10||Lucemyra||Lofexidine hydrochloride||[[Lofexidine hydrochloride]]||Lofexidine hydrochloride||5/16/2018
|-
| 2018||9||Akynzeo||Fosnetupitant and palonosetron||[[Fosnetupitant and palonosetron]]||Fosnetupitant and palonosetron||4/19/2018
|-
| 2018||8||Crysvita||Burosumab-twza||[[Burosumab-twza]]||Burosumab-twza||4/17/2018
|-
| 2018||7||Tavalisse||Fostamatinib||[[Fostamatinib]]||Fostamatinib||4/17/2018
|-
| 2018||6||Ilumya||Tildrakizumab||[[Tildrakizumab]]||Tildrakizumab||3/20/2018
|-
| 2018||5||Trogarzo||Ibalizumab-uiyk||[[Ibalizumab-uiyk]]||Ibalizumab-uiyk||3/6/2018
|-
| 2018||4||Erleada||Apalutamide||[[Apalutamide]]||Apalutamide||2/14/2018
|-
| 2018||3||Symdeko||Tezacaftor; ivacaftor||[[Tezacaftor; ivacaftor]]||Tezacaftor; ivacaftor||2/12/2018
|-
| 2018||2||Biktarvy||Bictegravir, embitcitabine, tenofovir alafenamide||[[Bictegravir, embitcitabine, tenofovir alafenamide]]||Bictegravir, embitcitabine, tenofovir alafenamide||2/7/2018
|-
| 2018||1||Lutathera||Lutetium lu 177 dotatate||[[Lutetium lu 177 dotatate]]||Lutetium lu 177 dotatate||1/26/2018
|}


<div style="-moz-column-count:3; column-count:3;">
:# [[Abemaciclib]]
:# [[Acalabrutinib]]
:# [[Amantadine (Gocovri)]]
:# [[Andexanet alfa]]
:# [[Angiotensin II (Giapreza)]]
:# [[Apalutamide]]
:# [[Avatrombopag]]
:# [[Avelumab]]
:# [[Axicabtagene ciloleucel]]
:# [[Benznidazole]]
:# [[Bictegravir / emtricitabine / tenofovir alafenamide]]
:# [[Brigatinib]]
:# [[Brodalumab]]
:# [[Burosumab]]
:# [[C1 esterase inhibitor subcutaneous (Haegarda)]]
:# [[Cerliponase alfa]]
:# [[Cetirizine ophthalmic solution (Zerviate)]]
:# [[Copanlisib]]
:# [[Dapagliflozin / saxagliptin]]
:# [[Daunorubicin / cytarabine]]
:# [[Deflazacort]]
:# [[Delafloxacin]]
:# [[Deutetrabenazine]]
:# [[Dolutegravir / rilpivirine]]
:# [[Dupilumab]]
:# [[Durvalumab]]
:# [[Edaravone]]
:# [[Emicizumab]]
:# [[Enasidenib]]
:# [[Erenumab]]
:# [[Ertugliflozin]]
:# [[Etelcalcetide]]
:# [[Fostamatinib]]
:# [[Glecaprevir / pibrentasvir]]
:# [[Guselkumab]]
:# [[Hydrogen peroxide (Eskata)]]
:# [[Ibalizumab]]
:# [[Inotuzumab ozogamicin]]
:# [[L-glutamine oral powder (Endari)]]
:# [[Latanoprostene bunod]]
:# [[Ledipasvir / sofosbuvir]]
:# [[Lesinurad / allopurinol (Duzallo)]]
:# [[Letermovir]]
:# [[Lofexidine]]
:# [[Lutetium Lu 177 dotatate]]
:# [[Macimorelin]]
:# [[Meropenem / vaborbactam (Vabomere)]]
:# [[Midostaurin]]
:# [[Naldemedine]]
:# [[Neratinib]]
:# [[Netarsudil]]
:# [[Niraparib]]
:# [[Ocrelizumab]]
:# [[Ombitasvir / paritaprevir / ritonavir / dasabuvir]]
:# [[Oxymetazoline hydrochloride]]
:# [[Ozenoxacin]]
:# [[Pegvaliase]]
:# [[Plecanatide]]
:# [[Rabies immune globulin (KedRab)]]
:# [[Coagulation factor IX, GlycoPEGylated (Rebinyn)]]
:# [[Hepatitis B Vaccine, adjuvanted (Heplisav-B)]]
:# [[Ribociclib]]
:# [[Safinamide]]
:# [[Sarilumab]]
:# [[Secnidazole]]
:# [[Semaglutide]]
:# [[Sodium zirconium cyclosilicate]]
:# [[Sofosbuvir / velpatasvir / voxilaprevir]]
:# [[Sofosbuvir / velpatasvir]]
:# [[Telotristat ethyl]]
:# [[Tezacaftor / ivacaftor]]
:# [[Tildrakizumab]]
:# [[Tisagenlecleucel]]
:# [[Tocilizumab]]
:# [[Tolvaptan]]
:# [[Triamcinolone acetonide (Zilretta)]]
:# [[Valbenazine]]
:# [[Vestronidase alfa]]
:# [[Voretigene neparvovec]]
:# [[Zoster vaccine, adjuvanted (Shingrix)]]
</div>
</div>
</div>

Revision as of 17:36, 19 June 2019

   Mission Statement   
   Tutorial   
   Editor's Checklist   

WikiDoc Drug Project — High-Priority Medications

List of high-priority medications

Year No. Brand Name Active Ingredient Page Link DailyMed Search Approval Date
2019 12 Polivy Polatuzumab vedotin-piiq Polatuzumab vedotin-piiq Polatuzumab vedotin-piiq 6/10/2019
2019 11 Piqray Alpelisib Alpelisib Alpelisib 5/24/2019
2019 10 Vyndaqel Tafamidis meglumine Tafamidis meglumine Tafamidis meglumine 5/3/2019
2019 9 Skyrizi Risankizumab-rzaa Risankizumab-rzaa Risankizumab-rzaa 4/23/2019
2019 8 Balversa Erdafitinib Erdafitinib Erdafitinib 4/12/2019
2019 7 Evenity Romosozumab-aqqg Romosozumab-aqqg Romosozumab-aqqg 4/9/2019
2019 6 Mayzent Siponimod Siponimod Siponimod 3/26/2019
2019 5 Sunosi Solriamfetol Solriamfetol Solriamfetol 3/20/2019
2019 4 Zulresso Brexanolone Brexanolone Brexanolone 3/19/2019
2019 3 Egaten Triclabendazole Triclabendazole Triclabendazole 2/13/2019
2019 2 Cablivi Caplacizumab-yhdp Caplacizumab-yhdp Caplacizumab-yhdp 2/6/2019
2019 1 Jeuveau Prabotulinumtoxina-xvfs Prabotulinumtoxina-xvfs Prabotulinumtoxina-xvfs 2/1/2019
2018 59 Ultomiris Ravulizumab Ravulizumab Ravulizumab 12/21/2018
2018 58 Elzonris Tagraxofusp-erzs Tagraxofusp-erzs Tagraxofusp-erzs 12/21/2018
2018 57 Asparlas Calaspargase pegol-mknl Calaspargase pegol-mknl Calaspargase pegol-mknl 12/20/2018
2018 56 Motegrity Prucalopride Prucalopride Prucalopride 12/14/2018
2018 55 Xospata Gilteritinib Gilteritinib Gilteritinib 11/28/2018
2018 54 Firdapse Amifampridine Amifampridine Amifampridine 11/28/2028
2018 53 Vitrakvi Larotrectinib Larotrectinib Larotrectinib 11/26/2018
2018 52 Daurismo Glasdegib Glasdegib Glasdegib 11/21/2018
2018 51 Gamifant Emapalumab-lzsgemapalumab-lzsg Emapalumab-lzsgemapalumab-lzsg Emapalumab-lzsgemapalumab-lzsg 11/20/2018
2018 50 Aemcolo Rifamycin Rifamycin Rifamycin 11/16/2018
2018 49 Yupelri Revefenacin Revefenacin Revefenacin 11/9/2018
2018 48 Lorbrena Lorlatinib Lorlatinib Lorlatinib 11/2/2018
2018 47 Xofluza Baloxavir marboxil Baloxavir marboxil Baloxavir marboxil 10/24/2018
2018 46 Talzenna Talazoparib Talazoparib Talazoparib 10/16/2018
2018 45 Tegsedi Inotersen Inotersen Inotersen 10/5/2018
2018 44 Revcovi Elapegademase-lvlr Elapegademase-lvlr Elapegademase-lvlr 10/5/2018
2018 43 Nuzyra Omadacycline Omadacycline Omadacycline 10/2/2018
2018 42 Seysara Sarecycline Sarecycline Sarecycline 10/1/2018
2018 41 Libtayo Cemiplimab-rwlc Cemiplimab-rwlc Cemiplimab-rwlc 9/28/2018
2018 40 Vizimpro Dacomitinib Dacomitinib Dacomitinib 9/27/2018
2018 39 Emgality Galcanezumab-gnlm Galcanezumab-gnlm Galcanezumab-gnlm 9/27/2018
2018 38 Copiktra Duvelisib Duvelisib Duvelisib 9/24/2018
2018 37 Ajovy Fremanezumab-vfrm Fremanezumab-vfrm Fremanezumab-vfrm 9/14/2018
2018 36 Lumoxiti Moxetumomab pasudotox-tdfk Moxetumomab pasudotox-tdfk Moxetumomab pasudotox-tdfk 9/13/2018
2018 35 Pifeltro Doravirine Doravirine Doravirine 8/30/2018
2018 34 Xerava Eravacycline Eravacycline Eravacycline 8/27/2018
2018 33 Takhzyro Lanadelumab Lanadelumab Lanadelumab 8/23/2018
2018 32 Oxervate Cenegermin-bkbj Cenegermin-bkbj Cenegermin-bkbj 8/22/2018
2018 31 Diacomit Stiripentol Stiripentol Stiripentol 8/20/2018
2018 30 Galafold Migalastat Migalastat Migalastat 8/10/2018
2018 29 Annovera Segesterone acetate and ethinyl estradiol vaginal system Segesterone acetate and ethinyl estradiol vaginal system Segesterone acetate and ethinyl estradiol vaginal system 8/10/2018
2018 28 Onpattro Patisiran Patisiran Patisiran 8/10/2018
2018 27 Poteligeo Mogamulizumab-kpkc Mogamulizumab-kpkc Mogamulizumab-kpkc 8/8/2018
2018 26 Mulpleta Lusutrombopag Lusutrombopag Lusutrombopag 7/31/2018
2018 25 Omegaven Fish oil triglycerides Fish oil triglycerides Fish oil triglycerides 7/27/2018
2018 24 Orilissa Elagolix sodium Elagolix sodium Elagolix sodium 7/23/2018
2018 23 Krintafel Tafenoquine Tafenoquine Tafenoquine 7/20/2018
2018 22 Tibsovo Ivosidenib Ivosidenib Ivosidenib 7/20/2018
2018 21 TPOXX Tecovirimat Tecovirimat Tecovirimat 7/13/2018
2018 20 Braftovi Encorafenib Encorafenib Encorafenib 6/27/2018
2018 19 Mektovi Binimetinib Binimetinib Binimetinib 6/27/2018
2018 18 Zemdri Plazomicin Plazomicin Plazomicin 6/25/2018
2018 17 Epidioloex Cannabidiol Cannabidiol Cannabidiol 6/25/2018
2018 16 Moxidectin Moxidectin Moxidectin Moxidectin 6/13/2018
2018 15 Olumiant Baricitinib Baricitinib Baricitinib 5/31/2018
2018 14 Palynziq Pegvaliase-pqpz Pegvaliase-pqpz Pegvaliase-pqpz 5/24/2018
2018 13 Doptelet Avatrombopag Avatrombopag Avatrombopag 5/21/2018
2018 12 Lokelma Sodium zirconium cyclosilicate Sodium zirconium cyclosilicate Sodium zirconium cyclosilicate 5/18/2018
2018 11 Aimovig Erenumab-aooe Erenumab-aooe Erenumab-aooe 5/17/2018
2018 10 Lucemyra Lofexidine hydrochloride Lofexidine hydrochloride Lofexidine hydrochloride 5/16/2018
2018 9 Akynzeo Fosnetupitant and palonosetron Fosnetupitant and palonosetron Fosnetupitant and palonosetron 4/19/2018
2018 8 Crysvita Burosumab-twza Burosumab-twza Burosumab-twza 4/17/2018
2018 7 Tavalisse Fostamatinib Fostamatinib Fostamatinib 4/17/2018
2018 6 Ilumya Tildrakizumab Tildrakizumab Tildrakizumab 3/20/2018
2018 5 Trogarzo Ibalizumab-uiyk Ibalizumab-uiyk Ibalizumab-uiyk 3/6/2018
2018 4 Erleada Apalutamide Apalutamide Apalutamide 2/14/2018
2018 3 Symdeko Tezacaftor; ivacaftor Tezacaftor; ivacaftor Tezacaftor; ivacaftor 2/12/2018
2018 2 Biktarvy Bictegravir, embitcitabine, tenofovir alafenamide Bictegravir, embitcitabine, tenofovir alafenamide Bictegravir, embitcitabine, tenofovir alafenamide 2/7/2018
2018 1 Lutathera Lutetium lu 177 dotatate Lutetium lu 177 dotatate Lutetium lu 177 dotatate 1/26/2018
Retrieved from "https://www.wikidoc.org/index.php?title=Drug_project_high-priority_medications&oldid=1572624"